Trimetrexate in the Treatment of Recurrent or Advanced Leiomyosarcoma of the Uterus: A Phase II Study of the Gynecologic Oncology Group

By Smith H.O.   Blessing J.A.   Vaccarello L.  

Gynecologic Oncology, Vol. 84, Iss. 1, 2002-01 ,pp. : 140-144

Elsevier

Access to resources Recommend Favorite

Phase II Study of Mitomycin, Doxorubicin, and Cisplatin in the Treatment of Advanced Uterine Leiomyosarcoma: A Gynecologic Oncology Group Study

By Edmonson J.H.   Blessing J.A.   Cosin J.A.   Miller D.S.   Cohn D.E.   Rotmensch J.  

Gynecologic Oncology, Vol. 85, Iss. 3, 2002-06 ,pp. : 507-510

Academic Press

Access to resources Recommend Favorite

Paclitaxel in the Treatment of Carcinosarcoma of the Uterus: A Gynecologic Oncology Group Study

By Curtin J.P.   Blessing J.A.   Soper J.T.   DeGeest K.  

Gynecologic Oncology, Vol. 83, Iss. 2, 2001-11 ,pp. : 268-270

Elsevier

Access to resources Recommend Favorite

A Phase III Trial of Ifosfamide with or without Cisplatin in Carcinosarcoma of the Uterus: A Gynecologic Oncology Group Study

By Sutton G.   Brunetto V.L.   Kilgore L.   Soper J.T.   McGehee R.   Olt G.   Lentz S.S.   Sorosky J.   Hsiu J.-G.  

Gynecologic Oncology, Vol. 79, Iss. 2, 2000-11 ,pp. : 147-153

Elsevier

Access to resources Recommend Favorite

Phase II study of Ifosfamide+Doxorubicin in patients with advanced synovial sarcomas (E1793): a trial of the Eastern Cooperative Oncology Group

By Edmonson John H.   Ryan Louise M.   Falkson Carla I.   Hicks David G.   Blum Ronald H.  

Sarcoma, Vol. 7, Iss. 1, 2003-01 ,pp. : 9-11

Informa Healthcare

Access to resources Recommend Favorite